Published Date: April 1, 2021 ,Last modified on April 1st, 2021

Lartbio

The market is flooded with protein supplements for the benefits they bring to the human body. However, the high cost of production, as well as the risks associated with protein production, poses several challenges. Lartbio, founded by Goo Jang, is set to be a pioneer in bovine-related products. Its game-changer strategy of a “Cattle Platform,” […]

Company Overview

The market is flooded with protein supplements for the benefits they bring to the human body. However, the high cost of production, as well as the risks associated with protein production, poses several challenges.

Lartbio, founded by Goo Jang, is set to be a pioneer in bovine-related products. Its game-changer strategy of a “Cattle Platform,” similar to the Amazon Platform model, to produce and sell a variety of bovine products for consumption, is unique.

Go-to-Market Strategy and Business Model

The short-term business model at Lartbio is embryo production. Currently, the company can produce embryos up to 300 straws every year, which is sold to Livestock Farm Owners and Inseminators for $500 each. It also plans to produce and sell a new breed of cattle like a super-muscle cow or non-prion cattle simultaneously. There are additional plans to open exclusive steakhouses with these new breeds. At a midterm stage, the company plans to produce designer milk for human consumption. Each cow produces 8000kg of milk every year, which is worth $12000. The ultimate goal is to create a biosimilar drug product. The company needs $17 million for research and investment in constructing its farm overseas. The company is looking to expand and create a long-term market. Their target market is $1 million in Korea. Reportedly, the global market size for Humanized Milk is $8.6 billion.

Founders' Bio

Goo Jang

  • About Lartbio
  • Location : Seoul, South Korea
  • Markets: BiotechnologyBovine productsHealthcare